Absorption and excretion of the soy isoflavone genistein in rats

Journal of Nutrition

Volumn 126, Issue 1, 1996, Pages 176-182

  King, Roger A ^a   Broadbent, Jessica L ^a   Head, Richard J ^b  

^a CSIRO   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

daidzein; genistein; pharmacokinetics; rats; soy

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; ISOFLAVONE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG FECES LEVEL; DRUG URINE LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SOYBEAN;

EID: 0030068459     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/126.1.176     Document Type: Article

References (28)

1. Axelson, M. & Setchell, K. D. R. (1981) The excretion of lignans in rats - evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett. 123: 337-342.
2. Axelson, M., Sjovall, J., Gustafsson, B. E. & Setchell, K. D. R. (1984) Soya-a dietary source of the non-steroidal oestrogen equol in man and animals. J. Endocrinol. 102: 49-56.
3. Barnes, S., Kirk, M. & Coward, L. (1994) Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J. Agric. Food Chem. 42: 2466-2474.
4. Brandi, M. L. (1992) Flavonoids: biochemical effects and therapeutic applications Bone Miner. 19 (Suppl.): S3-S14.
5. Bundavari, S. (ed.) (1989) The Merck Index, 11th ed., p. 441.
6. Griffiths, L. A. & Barrow, A. (1972) Metabolism of flavonoid compounds in germ-free rats. Biochem. J. 130: 1161-1162.
7. Griffiths, L. A. & Smith, G. E. (1972) Metabolism of apigenin and related compounds in the rat. Biochem. J. 128: 901-911.
8. Gugler, R., Leschik, M. & Dengler, H. J. (1972) Disposition of quercetin in man after single oral and intravenous doses. Angiologica 9: 162-174.
9. Hackett, A. M. & Griffiths, L. A. (1977) The disposition and metabolism of 3′, 4′, 7-tri-O-(β-hydroxyethyl) rutoside and 7-mono-O-(β-hydroxyethyl) rutoside in the mouse. Xenobiotica 7: 641-651.
10. Hertog, M. G. L , Feskens, E. J. M., Hollman, P. C. H., Katan, M. B. & Kromhout, D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342: 1007-1011.
11. Hutchins, A. M., Slavin, J. L. & Lampe, J. W. (1995) Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J. Am. Diet. Assoc. 95: 545-551.
12. Kelly, G. E., Nelson, C., Waring, M. A., Joannou, G. E. & Reeder, A. Y. (1993) Metabolites of dietary (soya) isoflavones in human urine. Clin. Chim. Acta 223: 9-22.
13. Lundh, T. (1995) Metabolism of estrogenic isoflavones in domestic animals. Proc. Soc. Exp. Biol Med. 208: 33-39.
14. Messina, M. J., Persky, V., Setchell, K. D. R. & Barnes, S. (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21: 113-131.
15. National Health and Medical Research Council, CSIRO and Australian Agricultural Research Council (1985) Code of practice for the care and use of animals for experimental purposes. Australian Government Publishing Service, Canberra, Australia.
16. Pereira, M. A., Barnes, L. H., Rassman, V. L., Kelloff, G. V. & Steele, V. E. (1994) Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15: 1049-1054.
17. Pettersson, H. & Kiessling, K.-H. (1984) Liquid chromatographic determination of the plant estrogens coumesterol and isoflavones in animal feed. J. Assoc. Off. Anal. Chem. 67: 503-506.
18. Record, I. R., Jannes, M , Dreosti, I. E. & King, R. A. (1995) The soy isoflavone genistein induces micronucleus formation in mouse splenocytes in vitro but not in vivo. Food Chem. Toxicol. (in press).
19. Rodbard, D. (1974) Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin. Chem. 20: 1255-1270.
20. Saito, A. M. (1985) Pharmacokinetic study of ipriflavone (TC-80) by oral administration in healthy male volunteers. Jpn. Pharmacol. Ther. J. 13: 7223-7233.
21. Sato, T., Koite, T., Hamada, A., Oshashi, M., Shimazu, A. (1986) Pharmacokinetics of ipriflavone tablets in long-term administration to patients with osteoporosis. Jpn. Pharmacol. Ther. J. 14: 873-883.
22. Setchell, K. D. R., Borriello, S. P., Huhne, P., Kirk, D. N. & Axelson, M. (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr. 40: 569-578.
23. Walter, E. D. (1941) Genistin (an isoflavone glucoside) and its aglycone, genistein, from soybeans. J. Am. Chem. Soc. 63: 3273-3276.
24. Wei, H., Bowen, R., Cai, Q., Barnes, S. & Wang, Y. (1995) Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 208: 124-130.
25. Xu, X., Wang, H.-J., Murphy, P. A., Cook, L. & Hendrich, S. (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124: 825-832.
26. Yoshida, K., Tsukamoto, T., Torii, H., Doi, T., Naeshiro, I., Shibata, K., Uemura, I. & Tanayama, S. (1985a) Metabolism of ipriflavone (TC-80) in rats. Radioisotopes 34: 612-617.
27. Yoshida, K., Tsukamoto, T., Torii, H., Doi, T., Naeshiro, I., Shibata, K., Uemura, I. & Tanayama, S. (1985b) Disposition of ipriflavone (TC-80) in rats and dogs. Radioisotopes 34: 618-623.
28. Yueh, T.-L. & Chu, H.-Y. (1977) The metabolic fate of daidzein. Scientia Sinica 20: 513-521.